2019
DOI: 10.1016/j.biopha.2018.11.017
|View full text |Cite
|
Sign up to set email alerts
|

ACY-1215 exhibits anti-inflammatory and chondroprotective effects in human osteoarthritis chondrocytes via inhibition of STAT3 and NF-κB signaling pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(30 citation statements)
references
References 45 publications
0
24
0
Order By: Relevance
“…However, nonselective HDAC inhibition may lead to potentially toxic and side effects due to the extensive acetylation of intracellular molecules. Therefore, selective HDACis may be safer and have lower side effects than nonselective HDACis (Prince et al, 2009; Cheng et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…However, nonselective HDAC inhibition may lead to potentially toxic and side effects due to the extensive acetylation of intracellular molecules. Therefore, selective HDACis may be safer and have lower side effects than nonselective HDACis (Prince et al, 2009; Cheng et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…In the presence of RU-486 (GR inhibitor), HDAC6 expression in MSCs is decreased which indicates that GR could regulate HDAC6 expression. In addition, tubacin (HDAC6 inhibitor) can weaken the complex formation between GR and HDAC6 ( 18 ). The association between HDAC6 and GR in the pathogenesis of GC-induced secondary osteoporosis will be investigated in a future study.…”
Section: Discussionmentioning
confidence: 99%
“…However, the specific role of HDAC6 in Dex-induced proliferation and differentiation of preosteoblasts remains to be elucidated. Ricolinostat (ACY-1215; an HDAC6 inhibitor) has been demonstrated to reduce inflammatory damage in osteoarthritis ( 18 ). However, further studies are required to determine whether it has any effect in osteoporosis.…”
Section: Introductionmentioning
confidence: 99%
“…Little is known on the role of HDAC5 in cartilage development and OA progression. HDAC5 acts as a co-activator of HDAC4 to inhibit chondrocyte hypertrophy through parathyroid hormone-related protein (PTHrP), which blocks the Mef2/Runx2 signaling pathway ( Cheng et al, 2019 ).…”
Section: Hdacs and Signaling Pathways In Cartilage Development And Oamentioning
confidence: 99%
“…Ricolinostat (ACY-1215) is a selective HDAC6 inhibitor that has anti-inflammatory and chondroprotective properties. ACY-1215 inhibits MMP1 and MMP13 expression by down regulating NF-κB and STAT3 activity in primary human chondrocyte stimulated with IL-1β ( Cheng et al, 2019 ).…”
Section: Hdac Inhibitors and Oa Treatmentmentioning
confidence: 99%